XML 65 R49.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation (Details) - Schedule of stock option activity - $ / shares
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Schedule of stock option activity [Abstract]    
Number of Options, Outstanding at Beginning Balance (in Shares) 496,471 136,489
Weighted Average Exercise Price Per Share, Outstanding at Beginning Balance $ 8.63 $ 27.85
Weighted Average Remaining Contractual Term (years), Outstanding at Beginning Balance 3 years 10 months 24 days 3 years 10 months 24 days
Aggregate Intrinsic Value, Outstanding at Beginning Balance [1]
Number of Options, Granted (in Shares) 598,649 370,397
Weighted Average Exercise Price Per Share, Granted $ 0.97 $ 1.37
Weighted Average Remaining Contractual Term (years), Granted 4 years 7 months 6 days 4 years 10 months 24 days
Aggregate Intrinsic Value, Granted [1]
Number of Options, Exercised (in Shares)
Weighted Average Exercise Price Per Share, Exercised
Weighted Average Remaining Contractual Term (years),Exercised
Aggregate Intrinsic Value, Exercised [1]
Number of Options, Forfeited (in Shares) (3,300) (10,415)
Weighted Average Exercise Price Per Share, Forfeited
Weighted Average Remaining Contractual Term (years), Forfeited
Aggregate Intrinsic Value, Forfeited [1]
Number of Options, Expired (in Shares) (4,000)
Weighted Average Exercise Price Per Share, Expired
Weighted Average Remaining Contractual Term (years), Expired [1]
Aggregate Intrinsic Value, Exercised, Expired [1]
Number of Options, Outstanding at Ending Balance (in Shares) 1,087,820 496,471
Weighted Average Exercise Price Per Share, Outstanding at Ending Balance $ 4.08 $ 8.63
Weighted Average Remaining Contractual Term (years), Outstanding at Ending Balance 3 years 10 months 24 days 3 years 10 months 24 days
Aggregate Intrinsic Value, Outstanding at Ending Balance [1]
Number of Options, Exercisable at Ending Balance (in Shares) 649,153  
Weighted Average Exercise Price Per Share, Exercisable at Ending Balance $ 5.38  
Weighted Average Remaining Contractual Term (years), Exercisable at Ending Balance 1 year 9 months 18 days  
Aggregate Intrinsic Value, Outstanding, Exercisable at Ending Balance [1]
[1] The aggregate intrinsic value on the table was calculated based on the difference between the estimated fair value of our stock and the exercise price of the underlying option. The estimated stock values used in the calculation was $0.98 and $1.73 per share for each of the years ended December 31, 2021 and 2020, respectively.